originality
发表于 2025-3-25 05:36:49
http://reply.papertrans.cn/39/3843/384281/384281_21.png
不理会
发表于 2025-3-25 08:24:03
http://reply.papertrans.cn/39/3843/384281/384281_22.png
生意行为
发表于 2025-3-25 12:15:29
http://reply.papertrans.cn/39/3843/384281/384281_23.png
是他笨
发表于 2025-3-25 18:20:57
http://reply.papertrans.cn/39/3843/384281/384281_24.png
口味
发表于 2025-3-25 21:52:59
http://reply.papertrans.cn/39/3843/384281/384281_25.png
脆弱么
发表于 2025-3-26 00:42:10
R. Orellana,P. Pulido,M. Briones,A. Sarabiaacodynamics, the large number of co-occurring chronic diseases, and consequent polypharmacy lead to these prescribing challenges. To avoid polypharmacy and optimize prescribing there are several tools and resources available. This chapter will describe these tools and resources including pharmacist
谎言
发表于 2025-3-26 07:16:03
https://doi.org/10.1007/978-3-8350-9244-0h attempts at curative or disease-modifying treatments. Goals of care typically evolve as an illness progresses, from primarily curative to primarily palliative as the end of life approaches. End-of-life issues are intertwined with issues of grief and loss. Clinicians should elicit these concerns an
不能平静
发表于 2025-3-26 08:40:49
http://reply.papertrans.cn/39/3843/384281/384281_28.png
变化无常
发表于 2025-3-26 15:01:08
http://reply.papertrans.cn/39/3843/384281/384281_29.png
陈旧
发表于 2025-3-26 20:44:19
http://reply.papertrans.cn/39/3843/384281/384281_30.png